BRIEF published on 12/16/2025 at 09:58, 3 hours 18 minutes ago Virbac acquires Thyronorm for the treatment of feline hyperthyroidism Acquisition Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
BRIEF published on 12/16/2025 at 09:58, 3 hours 18 minutes ago Virbac Acquires Thyronorm to Combat Feline Hyperthyroidism Veterinary Medicine Animal Health Feline Hyperthyroidism VIRBAC Thyronorm
PRESS RELEASE published on 12/16/2025 at 09:53, 3 hours 23 minutes ago VIRBAC: Feline Hyperthyroidism: Virbac acquires Thyronorm Virbac acquires innovative drug Thyronorm from Norbrook to stabilize feline hyperthyroidism, expanding distribution in key markets and enhancing senior cats' quality of life Acquisition Feline Hyperthyroidism VIRBAC Thyronorm Senior Cats
BRIEF published on 11/07/2025 at 15:44, 1 month 8 days ago Virbac: Update on shares and voting rights Euronext Paris Voting Rights Actions Transparency VIRBAC
BRIEF published on 09/12/2025 at 17:50, 3 months 3 days ago Virbac Reports Solid Growth in 2025 First Half Results Revenue Growth Operating Income VIRBAC 2025 Forecast Global Market Performance
PRESS RELEASE published on 09/12/2025 at 17:45, 3 months 3 days ago Virbac: 2025 Half-year results Virbac reports solid revenue growth of 5.6% in the first half of 2025, meeting adjusted operating income expectations. Targets for 2025 confirmed with revenue growth of 4-6% expected Financial Results Revenue Growth Operating Income VIRBAC Targets Confirmed
BRIEF published on 08/18/2025 at 09:35, 3 months 29 days ago Virbac reveals the remuneration of its new CEO General Manager Remuneration VIRBAC Free Shares Paul Martingell
PRESS RELEASE published on 08/18/2025 at 09:30, 3 months 29 days ago Virbac:: Paul Martingell's compensation terms Virbac's board of directors approves compensation terms for Paul Martingell as CEO, including fixed and variable components, long-term incentives, and exceptional benefits Board Of Directors CEO VIRBAC Paul Martingell Compensation Terms
BRIEF published on 07/04/2025 at 12:09, 5 months 12 days ago Virbac: Status of Shares and Voting Rights as of June 30, 2025 Euronext Paris Voting Rights Actions 2025 VIRBAC
PRESS RELEASE published on 07/04/2025 at 12:04, 5 months 12 days ago Virbac : Declaration of the number of shares and voting rights 06/2025 Declaration of the number of shares and voting rights for VIRBAC on Euronext Paris. Total voting rights: 12,706,453. Net total voting rights: 12,693,617 Euronext Paris Voting Rights Shares Financial Market Authority VIRBAC
Published on 12/16/2025 at 13:00, 16 minutes ago Abasca Resources Provides Exploration Update at its Loki Flake Graphite Deposit and Granting Stock Option
Published on 12/16/2025 at 13:00, 16 minutes ago Silver Wolf Completes Acquisition of the Ana Maria Project
Published on 12/16/2025 at 12:00, 1 hour 16 minutes ago Tokenwell Plans to Establish U.S. Subsidiary in Dallas, Texas, to Expand its Presence in the Growing Digital Asset Hub
Published on 12/16/2025 at 12:00, 1 hour 16 minutes ago CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
Published on 12/16/2025 at 12:00, 1 hour 16 minutes ago Snowline Gold Awards Key Contracts and Commences Prefeasibility Study on its Flagship Rogue Project, Yukon
Published on 12/16/2025 at 12:55, 21 minutes ago Banyan Group's Garrya Mu Cang Chai Opens in a National Heritage Site in Northern Vietnam
Published on 12/16/2025 at 12:22, 53 minutes ago REPLOID Group AG: HEROSAN launches crowdfunding campaign
Published on 12/16/2025 at 12:05, 1 hour 11 minutes ago BRP Announces Appointment of Denis Le Vot as President and Chief Executive Officer
Published on 12/16/2025 at 12:00, 1 hour 16 minutes ago DATAGROUP initiates delisting procedure on the Munich Stock Exchange
Published on 12/16/2025 at 11:49, 1 hour 26 minutes ago Strategic Investment: CANSOUL acquires stake in SYNBIOTIC
Published on 12/16/2025 at 08:30, 4 hours 46 minutes ago Cie du Bois Sauvage: Buy back of own shares – week from 08/12/2025 to 12/12/2025
Published on 12/15/2025 at 22:36, 14 hours 40 minutes ago Disclosure of trading in own shares between December 1st and December 5th, 2025
Published on 12/15/2025 at 18:30, 18 hours 46 minutes ago MCH PRIVATE EQUITY AND EURAZEO ENTER INTO AN EXCLUSIVE AGREEMENT WITH ARDIAN FOR THE SALE OF THEIR MAJORITY STAKE IN FERMAX
Published on 12/15/2025 at 18:05, 19 hours 11 minutes ago Covivio - Treasury shares transactions between December 8th , 2025 and December 12th, 2025
Published on 12/15/2025 at 17:45, 19 hours 31 minutes ago ENGIE strengthens the resilience of the Belgian electricity system with new flexible capacities
